Skip to main content

and
  1. Article

    Open Access

    Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

    Helmut Schütz, Divan A. Burger, Erik Cobo, David D. Dubins in The AAPS Journal (2024)

  2. Article

    Open Access

    Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

    Comparative bioavailability studies often involve multiple groups of subjects for a variety of reasons, such as clinical capacity limitations. This raises questions about the validity of pooling data from thes...

    Helmut Schütz, Divan A. Burger, Erik Cobo, David D. Dubins in The AAPS Journal (2024)

  3. No Access

    Article

    A genome-wide view of disordered proteins

    Transcription factors containing disordered regions can now be mapped across the genome, aiding functional studies.

    Benjamin J. Leslie, Benjamin Lang, M. Madan Babu in Nature Biotechnology (2024)

  4. Article

    Open Access

    A systematic review of the development and application of home cage monitoring in laboratory mice and rats

    Traditionally, in biomedical animal research, laboratory rodents are individually examined in test apparatuses outside of their home cages at selected time points. However, the outcome of such tests can be inf...

    Pia Kahnau, Paul Mieske, Jenny Wilzopolski, Otto Kalliokoski in BMC Biology (2023)

  5. Article

    Open Access

    Defining the condensate landscape of fusion oncoproteins

    Fusion oncoproteins (FOs) arise from chromosomal translocations in ~17% of cancers and are often oncogenic drivers. Although some FOs can promote oncogenesis by undergoing liquid-liquid phase separation (LLPS)...

    Swarnendu Tripathi, Hazheen K. Shirnekhi, Scott D. Gorman in Nature Communications (2023)

  6. Article

    Open Access

    Bioequivalence of Intravenous Alteplase from Two Different Manufacturing Processes in Healthy Male Volunteers: Results from a Two-Stage, Adaptive-Design Study

    Alteplase is a recombinant tissue plasminogen activator used for thrombolytic treatment in several indications and is currently approved in Europe under the brand name Actilyse®. The current manufacturing process...

    Stephan Glund, Josef Hoefler, Benjamin Lang, Stephen Cafiero in Clinical Pharmacokinetics (2023)

  7. Article

    Open Access

    Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

    BI 695501 is an FDA-approved biosimilar to adalimumab reference product (RP). VOLTAIRE-X was a randomized clinical trial to assess outcomes with a biosimilar monoclonal antibody in line with the FDA requiremen...

    Alan Menter, Stanley Cohen, Jonathan Kay in American Journal of Clinical Dermatology (2022)

  8. Article

    Open Access

    Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes

    Breast cancer is a heterogeneous disease classified into four main subtypes with different clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for the differential diagno...

    Claudia Cava, Alexandros Armaos, Benjamin Lang, Gian G. Tartaglia in Scientific Reports (2022)

  9. No Access

    Article

    A community effort to bring structure to disorder

    With protein structure prediction recently getting a seismic boost in accuracy, hopes are also up to better predict unstructured protein regions that can adopt diverse conformations. CAID, a community effort t...

    Benjamin Lang, M. Madan Babu in Nature Methods (2021)

  10. Article

    Open Access

    Molecular relaxation effects on vibrational water vapor photoacoustic spectroscopy in air

    Photoacoustic spectroscopy is a highly sensitive technique, well suited for and used in applications targeting the accurate measurement of water vapor in a wide range of concentrations. This work demonstrates ...

    Benjamin Lang, Philipp Breitegger, Georg Brunnhofer in Applied Physics B (2020)

  11. Article

    Open Access

    Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials

    BI 695501 has shown similar efficacy, safety, and immunogenicity to the adalimumab reference product, Humira®. We present two phase 1 studies comparing the pharmacokinetics, safety, and immunogenicity of BI 69550...

    Steven Ramael, Benjamin Van Hoorick, Renger Tiessen in Rheumatology and Therapy (2018)

  12. Article

    Open Access

    Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline

    Diminishing potential to replace damaged tissues is a hallmark for ageing of somatic stem cells, but the mechanisms remain elusive. Here, we present proteome-wide atlases of age-associated alterations in human...

    Marco L. Hennrich, Natalie Romanov, Patrick Horn, Samira Jaeger in Nature Communications (2018)

  13. No Access

    Article

    A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs

    A drug is defined as highly variable if its intra-individual coefficient of variation (CV) is greater than or equal to 30%. In such a case, bioequivalence may be assessed by means of methods that take the (hig...

    Sophie I. E. Knahl, Benjamin Lang in European Journal of Clinical Pharmacology (2018)

  14. Article

    Open Access

    Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study

    Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation. Safety, pharmacokinetics and pharmacodynamics of idarucizumab were investigated in dabigatran-treated, middl...

    Stephan Glund, Joachim Stangier, Joanne van Ryn in Clinical Pharmacokinetics (2017)

  15. Article

    Dynamical Locality of the Free Maxwell Field

    The extent to which the non-interacting and source-free Maxwell field obeys the condition of dynamical locality is determined in various formulations. Starting from contractible globally hyperbolic spacetimes,...

    Christopher J. Fewster, Benjamin Lang in Annales Henri Poincaré (2016)

  16. No Access

    Article

    Quantization of Maxwell’s Equations on Curved Backgrounds and General Local Covariance

    We develop a quantization scheme for Maxwell’s equations without source on an arbitrary oriented four-dimensional globally hyperbolic spacetime. The field strength tensor is the key dynamical object and it is ...

    Claudio Dappiaggi, Benjamin Lang in Letters in Mathematical Physics (2012)

  17. No Access

    Protocol

    Methods to Reconstruct and Compare Transcriptional Regulatory Networks

    The availability of completely sequenced genomes and the wealth of literature on gene regulation have enabled researchers to model the transcriptional regulation system of some organisms in the form of a netwo...

    M. Madan Babu, Benjamin Lang, L. Aravind in Computational Systems Biology (2009)